Psychedelic drugs often conjure images of the colorful, mind-bending world of 1960s counterculture. But therapists and scientists at the time also used these drugs to treat and research issues such as depression, alcoholism and anxiety. However, when publicity began to take a negative turn, focusing on bad trips, psychotic breaks, flashbacks and suicides, the drugs became illegal and largely unattainable—until now.

In his fascinating book How to Change Your Mind, bestselling author Michael Pollan (The Omnivore's Dilemma, Cooked) discusses the recent psychedelic drug resurgence. Starting in the 1990s, a new generation of scientists began to quietly reinvestigate the potential of these drugs, not only to treat mental illnesses and addiction but also to help cancer patients cope with the prospect of dying and "explore the links between the brain and mind, hoping to unravel some of the mysteries of consciousness."

Pollan discusses the different types of psychedelic drugs and their history in detail, from plant-based forms such as psilocybin (mushrooms) and mescaline (cacti) to LSD (synthetically produced). The current psychedelic renaissance piqued his interest and prompted him to do his own exploration. He devotes a whole chapter, appropriately named "Travelogue," to these encounters. He writes, "Psychedelic experiences are notoriously hard to render in words," but he does his best, thoughtfully deeming a "trip" as the relinquishment of the ego power struggle most of us go through every day.

As Pollan describes, this altered state of consciousness can be spiritually enlightening, mind-opening and life-changing. It can also be terror-provoking. How to Change Your Mind chronicles the unusual power of these substances, instilling a better understanding of their capabilities in helping to discover, heal and change our minds. It's a trip worth taking.

 

This article was originally published in the May 2018 issue of BookPage. Download the entire issue for the Kindle or Nook.

Before Timothy Leary encouraged Sixties counterculturalists to turn on, tune in, and drop out, scientists and doctors saw LSD and other psychedelics as tremendous new tools for understanding consciousness. Now, these back-burnered drugs are proving effective in treating such disorders as PTSD and depression. New York Timesbest-selling author Pollan even put himself forth as guinea pig.

Journalist and author Pollan (Univ. of California Berkeley Graduate Sch. of Journalism; The Omnivore's Dilemma) dives into the history, science, and mystery of psychedelics: the infamous category of "mind manifesting" substances at once fairly and unfairly associated with 1960s counterculture. Today psychedelics are experiencing a renaissance in scientific research and culture, which shows promising signs of both unraveling past stereotypes and developing new approaches to the brain, consciousness, and treatments for mental illness. To illustrate this shift, Pollan presents a variety of perspectives, including his own "travelog" of forays with LSD and more. The result is a mixture of captivating journalism and unfortunately slightly awkward storytelling; the latter a consequence of the author's occasional discomfort with his own relationship to the topic. This book can set one a little off-kilter but is true to its ultimate goal: to get readers to open their minds and consider what psychedelics might yet teach us about ourselves and what we don't know. VERDICT A work of participatory journalism that shines new light on psychedelics and the people who study them. Recommended for fans of Pollan, science journalism, and studies of the mind.—Robin Chin Roemer, Univ. of Washington Lib., Seattle

Food writer Pollan (Cooked) shifts his focus to other uses of plants in this brilliant history of psychedelics across cultures and generations, the neuroscience of its effects, the revival of research on its potential to heal mental illness—and his own mind-changing trips. For an entire generation, psychedelics were synonymous with Harvard professor-turned-hippie Timothy Leary and his siren call to "turn on, tune in, drop out." But, Pollan argues, that freewheeling attitude quickly turned into a "full-on moral panic about LSD" that "doomed the first wave of research." By the 1990s, the body of knowledge about the successful use of LSD to treat alcoholics in the '50s and '60s was buried, and medical interest only revived in 2010 with studies on treating cancer anxiety with psilocybin. Pollan writes movingly of one man whose "psychedelic journey had shifted his perspective from a narrow lens trained on the prospect of dying to a renewed focus on how best to live the time left to him." Today, renewed interest has sent scientists racing ahead with trials of psychedelics to treat addiction and depression, and curious seekers like Pollan into experiments with these substances. This nuanced and sophisticated exploration, which asks big questions about meaning-making and spiritual experience, is thought-provoking and eminently readable. Agent: Amanda Urban, ICM. (May)